Description

Erlonat 100 mg (Erlotinib) – Targeted Treatment for Certain Cancers

Erlonat 100 mg is a prescription anticancer medicine containing Erlotinib 100mg, a tyrosine kinase inhibitor (TKI). It works by blocking epidermal growth factor receptor (EGFR) signaling, which can help slow the growth and multiplication of certain cancer cells.

Erlonat 100 mg is primarily used for selected cases of non-small cell lung cancer (NSCLC) and may also be used with gemcitabine for pancreatic cancer. For NSCLC, treatment may depend on the presence of specific EGFR mutations. This medicine should only be used under the supervision of a qualified oncologist.

• Key Features

1. Contains Erlotinib 100mg per tablet
2. Prescription-only targeted anticancer medicine
3. Belongs to the tyrosine kinase inhibitor class
4. Targets EGFR signaling in certain cancer cells
5. Used for selected cases of lung and pancreatic cancer
6. Oral tablet for convenient administration

How to Take Erlonat 100 mg

Take Erlonat 100 mg exactly as prescribed by your oncologist. Swallow the tablet whole with a glass of water.

Erlonat is generally taken on an empty stomach, at least 1 hour before or 2 hours after food, as food can affect Erlotinib absorption.

Take the medicine at approximately the same time each day. Do not change the dose or stop treatment without consulting your oncologist.

• General Dosage Reference

Medical Condition	Recommended Adult Dose
Non-Small Cell Lung Cancer (NSCLC)	150mg once daily or as prescribed
Pancreatic Cancer	100mg once daily, usually with gemcitabine, or as prescribed

The exact dosage and treatment duration should always be determined by the treating oncologist based on cancer type, EGFR status, overall health, liver function, and treatment response.

Safety Information

Before starting Erlonat 100 mg, inform your healthcare provider if you have liver disease, kidney problems, lung disorders, gastrointestinal problems, or eye conditions.

Tell your doctor about all prescription medicines, over-the-counter medicines, vitamins, and supplements you take, as Erlotinib can interact with several medicines.

Pregnant or breastfeeding women should consult their healthcare provider before using Erlonat. Smoking may reduce the effectiveness of Erlotinib.

Common side effects may include skin rash, diarrhea, dry skin, loss of appetite, tiredness, nausea, and mouth sores.

Seek immediate medical attention for severe diarrhea, breathing difficulties, severe skin reactions, eye problems, severe abdominal pain, or signs of liver problems.

Product Specifications

Specification	Information
Brand	Erlonat
Generic Name	Erlotinib
Active Ingredient	Erlotinib
Strength	100mg
Dosage Form	Oral Tablet
Drug Class	Tyrosine Kinase Inhibitor
Target	EGFR
Route of Administration	Oral
Prescription Status	Prescription Required
Storage	Store according to the manufacturer’s labeled instructions

Frequently Asked Questions

What is Erlonat 100 mg used for?
Erlonat 100 mg is used for selected cases of non-small cell lung cancer and pancreatic cancer, depending on the patient’s cancer type and clinical characteristics.

Is Erlonat 100 mg a chemotherapy medicine?
Erlonat is a targeted anticancer medicine known as an EGFR tyrosine kinase inhibitor. It works differently from traditional chemotherapy.

How should Erlonat 100 mg be taken?
It is generally taken on an empty stomach, at least 1 hour before or 2 hours after food, or exactly as directed by your oncologist.

What are the common side effects?
Common side effects include skin rash, diarrhea, dry skin, tiredness, loss of appetite, nausea, and mouth sores.

Can I stop taking Erlonat when I feel better?
No. Continue Erlonat for the duration prescribed by your oncologist. Do not stop or change the dose without medical advice.